Evidence map›Paper›PMID 37497325›Full record

ArticleOpen respiratory archives

[Positioning Document of Spanish Society of Pulmonology and Thoracic Surgery (SEPAR) on Tobacco Harm Reduction Strategies].

Carlos A Jiménez Ruiz, Segismundo Solano-Reina, Eva de Higes-Martínez, Eva Cabrera-César, Raúl Sandoval-Contreras, José Ignacio de Granda-Orive, Juan Antonio Riesco-Miranda, Jaime Signes-Costa Miñana, José Javier Lorza-Blasco, Manuel Ángel Martínez-Muñiz and 1 more

Open access · goldAbstract readEnglish Abstract
In one paragraph

Article in Open respiratory archives. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.9field-weighted citation impact, top 27% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 8 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 11 institutions in 1 country.

Carlos A Jiménez RuizUnidad Especializada en Tabaquismo de la Comunidad de Madrid, Hospital Clínico San Carlos, Madrid, España.
Segismundo Solano-ReinaServicio de Neumología, Hospital General Universitario Gregorio Marañón, Madrid, España.
Eva de Higes-MartínezUnidad de Neumología, Hospital Universitario Fundación Alcorcón, España.
Eva Cabrera-CésarServicio de Neumología, Hospital Universitario Virgen de la Victoria, Málaga, España.
Raúl Sandoval-ContrerasServicio de Neumología, Hospital Virgen de los Lirios, Alcoy, Alicante.
José Ignacio de Granda-OriveServicio de Neumología, Hospital Universitario 12 de Octubre, Madrid, España.
Juan Antonio Riesco-MirandaServicio de Neumología, Hospital Universitario de Cáceres, Cáceres, España.
Jaime Signes-Costa MiñanaServicio de Neumología, Hospital Clínico Universitario de Valencia, España.
José Javier Lorza-BlascoServicio de Neumología, Complejo Hospitalario de Navarra, Pamplona, España.
Manuel Ángel Martínez-MuñizServicio de Neumología, Hospital Universitario San Agustín, Avilés, España.
Carlos Rábade-CastedoServicio de Neumología, Complejo Hospitalario Universitario de Santiago de Compostela, Santiago de Compostela, España.
Centro de Investigación Biomédica en Red de Enfermedades Respiratorias · ESComplejo Hospitalario de Navarra · ESComplejo Hospitalario Universitario de Santiago · ESHospital Clínico San Carlos · ESHospital Clínico Universitario de Valencia · ESHospital Clínico Universitario Virgen de la Victoria · ESHospital General Universitario Gregorio Marañón · ESHospital Universitario San Agustín · ESHospital Virgen de los Lirios · ESUniversidad Complutense de Madrid · ESUniversidad Rey Juan Carlos · ES

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

In the last decade, the appearance of electronic cigarettes and new tobacco products (heated tobacco or smokeless tobacco) has generated a growing interest in harm reduction methods that are defined as mechanisms that seek to reduce the harmful consequences of tobacco without give up the pleasant effects of it by replacing it with these new electronic devices. However, these products are addictive and not safe as they contain nicotine. Harm reduction is a false solution as it represents a commercial strategy of the tobacco industry to increase its sales, making it difficult to control smoking, since it keeps smokers from consuming tobacco and prevents them from making serious attempts to quit. In addition, these products are a gateway to adolescents in tobacco.

Indexed as

Electronic cigarrettesHarm reductionHeated tobaccoSmoking

Identifiers

PMID37497325
PMCPMC10369613
OpenAlexW4224990380

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.